02-11-2021, 07:32 PM
MrNoBody wrote:
Any guesses on when Novo Nordisk will get this approved for ACA & Medicaid payment?
c'mon, you know the lobbyists are already hard at work...
“Generally, insurers have refused to pay for the weight-loss drugs on the market. Semaglutide is likely to be expensive. The lower dose used to treat diabetes carries an average retail price of nearly $1,000 a month. (Insurers usually pay for diabetes drugs, Dr. Kushner noted.)”